Go to the list of all blogs
M. Benett's Avatar
published in Blogs
Aug 11, 2026
Tower Semiconductor (TSEM) Declines -10.5% Over 30 Days After Japan Expansion News

Tower Semiconductor (TSEM) Declines -10.5% Over 30 Days After Japan Expansion News

Key Takeaways

  • Tower Semiconductor shares fell approximately 10.5% over the past 30 days, declining from $245.46 on July 1 to $219.67 at the July 31 close.
  • The decline followed a sharp rally triggered by the company's July 14 announcement of a $3 billion Japan expansion plan, after which profit-taking and sector-wide volatility drove shares lower.
  • Over the broader quarter, TSEM experienced extreme swings — surging to an all-time high of $319.94 in late June before a steep correction pushed shares as low as $187.84 on July 29.
  • Strong business fundamentals remain intact: Q1 2026 revenue grew 15% year-over-year to $414 million, and the company has secured $1.3 billion in contracted silicon photonics revenue for 2027.
  • Investors are closely watching the upcoming Q2 2026 earnings report, which management previously guided to be the highest quarterly revenue in company history at approximately $455 million.

Tower Semiconductor (TSEM) Company Overview and Market Position

Tower Semiconductor (TSEM) is a leading specialty foundry that manufactures analog and mixed-signal semiconductor chips for customers across high-growth markets, including data centers, automotive electronics, mobile devices, industrial applications, and IoT. The company operates fabrication facilities in Israel, the United States, Japan, and Italy, delivering customizable process technologies such as silicon photonics (SiPho), silicon germanium (SiGe), RF CMOS, power management, and CMOS image sensors. Tower's silicon photonics platform has emerged as a critical differentiator, enabling optical data transmission that replaces traditional copper interconnects in AI data centers. With over 50 active SiPho customers and multi-year contracts with major hyperscaler partners including Marvell Technology (MRVL), Tower has positioned itself as an essential supplier in the AI infrastructure supply chain. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Tower Semiconductor (TSEM) Stock Price Performance: Last 30 Days vs. Quarter

Over the last 30 days, TSEM shares declined from a closing price of $245.46 on July 1, 2026, to $219.67 on July 31, 2026, representing a drop of approximately 10.5%. The stock's 30-day trajectory was far from linear: shares surged roughly 11% on July 14 following the Japan capacity expansion announcement, reaching $255.49, only to reverse sharply in the ensuing weeks as profit-taking, macroeconomic uncertainty, and elevated valuation concerns weighed on investor sentiment. The stock briefly touched an intra-month low of $187.84 on July 29 before rebounding over 16% in the final two trading sessions of the month amid a broader rally in optical communications equities.

The quarterly picture reflects even greater turbulence. After starting the quarter near $252 at the beginning of June, TSEM rocketed to a 52-week high of $319.94 on June 22, fueled by enthusiasm around AI-driven silicon photonics demand and growing customer commitments. That peak proved unsustainable, as a sharp correction in the final week of June and continued selling pressure through July erased roughly 31% from the June peak to the late-July trough, before the modest recovery brought quarterly losses into the low double digits.

What Drove TSEM Stock Price in the Last 30 Days

The defining catalyst of the 30-day period was Tower Semiconductor's July 14 announcement of a dual-track strategic capacity expansion in Japan, supported by a $1 billion grant from the Japanese government. The plan involves repurposing the Arai facility for 300mm silicon photonics production and constructing a new manufacturing facility adjacent to Fab 7, with a total net investment of approximately $3 billion. Management concurrently raised its 2028 financial targets to $3.6 billion in revenue and $1.2 billion in net profit, up from prior targets of $2.8 billion and $750 million. The initial market reaction was strongly positive, sending shares sharply higher.

However, the rally proved short-lived. Several factors contributed to the subsequent sell-off. First, the stock's elevated valuation — trading at a trailing price-to-earnings ratio above 100 — made it vulnerable to profit-taking after the initial news-driven spike. Second, broader semiconductor sector sentiment turned cautious in late July, with macro concerns about global trade policy and interest rate expectations triggering rotation out of high-multiple growth names. Third, reports that institutional investor Sei Investments Co. trimmed its TSEM position by 39.3% in Q1, along with other rebalancing activity, added selling pressure. Finally, anticipation of the company's Q2 earnings release scheduled for August 4 created a degree of event-driven uncertainty, with options market implied volatility rising into the print. From what I see, this combination of factors explains much of the pullback.

What Drove TSEM Stock Performance Over the Last Quarter

The quarterly narrative was defined by the market's evolving assessment of Tower Semiconductor's silicon photonics opportunity. The company's Q1 2026 earnings report in mid-May established strong momentum: revenue of $414 million grew 15% year-over-year, net profit surged 62% to $65 million, and management guided for record Q2 revenue of $455 million. Critically, Tower disclosed $1.3 billion in contracted SiPho revenue for 2027 and $290 million in customer prepayments — signals of extraordinary demand visibility that propelled the stock to its June peak. I also checked this using Tickeron’s AI Trend Prediction Engine to review historical patterns around similar announcements.

The subsequent correction reflected a broader recalibration. While the long-term silicon photonics thesis remained intact, investors grew cautious about near-term execution risks associated with the $3 billion capital expenditure program, potential margin compression during the capacity build-out phase, and the high-price-multiple sensitivity to any disappointment. Analyst reactions were mixed but generally constructive: Susquehanna raised its price target to $330 with a Positive rating, Benchmark reiterated Buy with a $335 target, and Wedbush maintained Neutral with a $300 target. The average analyst price target of $276.75 suggested considerable upside from late-July levels, though near-term volatility persisted.

TSEM Stock Forecast Drivers: What Investors Should Watch Next

The most immediate catalyst is Tower Semiconductor's Q2 2026 earnings report, expected around August 4, where analysts project earnings of $0.73 per share on revenue of approximately $454.68 million. Beyond the headline numbers, investors will scrutinize updates on silicon photonics capacity utilization, progress on the Japan expansion timeline, gross margin trajectory, and any revisions to full-year 2026 guidance. Longer term, the company's ability to execute on the dual-track Japan build-out — with the Arai facility targeting production readiness by Q4 2027 — will be the primary determinant of whether Tower can meet its ambitious $3.6 billion 2028 revenue target. Macroeconomic factors including semiconductor trade policy, Japanese yen fluctuations affecting construction costs, and AI infrastructure spending trends at major hyperscalers also warrant close monitoring. The stock's premium valuation means that any execution misstep or demand slowdown could trigger disproportionate price reactions. I'm watching this closely as the earnings date approaches.

Exploring Tickeron AI Tools

In my own research process, I frequently turn to Tickeron’s Trending AI Robots for additional perspective on market movements. The platform highlights top-performing algorithmic trading bots across equities and other assets, with performance metrics and strategy details that help align automated approaches with current conditions. These tools allow for a more data-driven review of volatility and opportunity without replacing core fundamental analysis.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: TSEM

Momentum Indicator for TSEM turns positive, indicating new upward trend

TSEM saw its Momentum Indicator move above the 0 level on August 07, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 79 similar instances where the indicator turned positive. In of the 79 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 51 cases where TSEM's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for TSEM just turned positive on August 06, 2026. Looking at past instances where TSEM's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

TSEM moved above its 50-day moving average on August 07, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where TSEM advanced for three days, in of 311 cases, the price rose further within the following month. The odds of a continued upward trend are .

TSEM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The 10-day moving average for TSEM crossed bearishly below the 50-day moving average on July 08, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TSEM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for TSEM entered a downward trend on July 31, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. TSEM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.242) is normal, around the industry mean (8.289). P/E Ratio (99.783) is within average values for comparable stocks, (163.639). TSEM's Projected Growth (PEG Ratio) (6.450) is slightly higher than the industry average of (1.924). TSEM has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.015). P/S Ratio (16.863) is also within normal values, averaging (47.761).

Notable companies

The most notable companies in this group are NVIDIA Corp (NASDAQ:NVDA), Broadcom Inc. (NASDAQ:AVGO), Taiwan Semiconductor Manufacturing Company Ltd (NYSE:TSM), Micron Technology (NASDAQ:MU), Advanced Micro Devices (NASDAQ:AMD), Intel Corp (NASDAQ:INTC), Texas Instruments (NASDAQ:TXN), Marvell Technology (NASDAQ:MRVL), Analog Devices (NASDAQ:ADI), QUALCOMM (NASDAQ:QCOM).

Industry description

The semiconductor industry manufacturers all chip-related products, including research and development. These chips are used in innumerable electronic devices, including computers, cell phones, smartphones, and GPSs. Intel Corporation, NVIDIA Corp., and Broadcomm are some of the prominent players in this industry. Semiconductor companies usually tend to do well during periods of healthy economic growth, thereby inducing further research and development in the industry – which in turn augurs well for productivity and growth in the economy. In the near future, demand for semiconductor products (and possibly innovation within the segment) should only expand further, with the proliferation of 5G, autonomous vehicles, IoT, and various AI-driven electronics set to herald a new, advanced chapter in the technology-driven world as we know it. With burgeoning prospects comes great competition. In 2015, SIA estimated that U.S. semiconductor industry ranks as the second most competitive U.S. industry out of 2882 U.S. industries designated manufacturers by the U.S. Census Bureau.

Market Cap

The average market capitalization across the Semiconductors Industry is 187.41B. The market cap for tickers in the group ranges from 13.43K to 5.27T. NVDA holds the highest valuation in this group at 5.27T. The lowest valued company is CYBL at 13.43K.

High and low price notable news

The average weekly price growth across all stocks in the Semiconductors Industry was -0%. For the same Industry, the average monthly price growth was -7%, and the average quarterly price growth was 45%. SITM experienced the highest price growth at 25%, while LASR experienced the biggest fall at -27%.

Volume

The average weekly volume growth across all stocks in the Semiconductors Industry was -11%. For the same stocks of the Industry, the average monthly volume growth was -10% and the average quarterly volume growth was -52%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 60
P/E Growth Rating: 53
Price Growth Rating: 46
SMR Rating: 75
Profit Risk Rating: 73
Seasonality Score: -26 (-100 ... +100)
View a ticker or compare two or three
TSEM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a manufacturer of integrated circuits and customizable wafer processes

Industry Semiconductors

Profile
Details
Industry
Semiconductors
Address
20 Shaul Amor Avenue
Phone
+972 46506109
Employees
5613
Web
https://www.towersemi.com
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.